Patient Outcomes after Hepatic Artery Infusion Pump Placement

Overview

About this study

The purpose of this study is to evaluate the short-term outcomes and the quality of life (QOL) after cholecystectomy and hepatic artery infusion pump placement for localized unresectable colorectal liver metastases (CRLM).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients who receive a Hepatic Artery Infusion Pump at Mayo Clinic Rochester for localized unresectable liver metastases from colorectal cancer.
Age ≥ 18 years old.
Written consent.

Exclusion Criteria:

Age < 18 years old.
Absence of written consent.
Systemic disease.
Pregnancy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Cornelius Thiels, D.O., M.B.A.	Open for enrollment	Contact information: Summer Auerbach (507) 422-9153 Auerbach.Summer@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Cornelius Thiels, D.O., M.B.A.

Open for enrollment

Contact information:

Summer Auerbach

(507) 422-9153

Auerbach.Summer@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials